LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 44.89 | 771.67 | 3085 | 5541 | 0.5567 | 0.6278 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 47.11 | 771.67 | 2969 | 5941 | 0.4997 | 0.5802 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 47.11 | 771.67 | 3343 | 5941 | 0.5627 | 0.6452 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 49.33 | 771.67 | 3168 | 6392 | 0.4956 | 0.5888 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 49.33 | 771.67 | 3518 | 6392 | 0.5503 | 0.6444 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 51.55 | 771.67 | 3419 | 6829 | 0.5006 | 0.6051 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 51.55 | 771.67 | 3728 | 6829 | 0.5459 | 0.6499 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 53.77 | 771.67 | 3629 | 7256 | 0.5001 | 0.6142 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 53.77 | 771.67 | 3980 | 7256 | 0.5485 | 0.6610 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 55.99 | 771.67 | 3793 | 7690 | 0.4932 | 0.6162 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 55.99 | 771.67 | 4205 | 7690 | 0.5468 | 0.6672 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.21 | 771.67 | 4069 | 8085 | 0.5033 | 0.6332 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 58.21 | 771.67 | 4457 | 8085 | 0.5512 | 0.6777 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.44 | 771.67 | 4280 | 8530 | 0.5017 | 0.6392 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 60.44 | 771.67 | 4629 | 8530 | 0.5426 | 0.6767 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.66 | 771.67 | 4476 | 8978 | 0.4985 | 0.6430 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.66 | 771.67 | 4868 | 8978 | 0.5422 | 0.6824 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.88 | 771.67 | 4651 | 9447 | 0.4923 | 0.6439 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.88 | 771.67 | 5021 | 9447 | 0.5315 | 0.6791 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.10 | 771.67 | 4805 | 9800 | 0.4903 | 0.6467 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.10 | 771.67 | 5202 | 9800 | 0.5308 | 0.6827 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.32 | 771.67 | 5096 | 10212 | 0.4990 | 0.6596 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.32 | 771.67 | 5481 | 10212 | 0.5367 | 0.6924 | MN20160304_L01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.54 | 771.67 | 5316 | 10532 | 0.5047 | 0.6683 | MN20160304_L01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.54 | 771.67 | 5682 | 10532 | 0.5395 | 0.6980 | MN20160304_L01 | N13 |